V
主页
京东 11.11 红包
Insulin-like Growth Factors and Kidney Disease
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
Targeting the insulin-like growth factor-1 receptor in
Complement C5a induces renal injury in diabetic kidney disease
Dapagliflozin in Patients with Chronic Kidney Disease(2020/9)
Effects of finerenone in people with chronic kidney disease(0416.165754)
Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance
Gut Mycobiome in Patients With Chronic Kidney Disease Was Altered and Associated
Moutan Cortex polysaccharide ameliorates diabetic kidney disease via Gut microbe
Race ,genetic ancestry,and estimating kidney function in CKD
Lactiplantibacillus plantarum J-15 reduced calcium oxalate kidney stones
Probiotic Lactiplantibacillus plantarum N-1 could prevent kidney stone formation
Exosome-based Delivery of Super-Repressor IĸBα Ameliorates Kidney Ischemia-Reper
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
Annexin A1 alleviates kidney injury by promoting the resolution of inflammation
adolescent BP and the risk for early kidney damage in young adulthood
KN is linked to disease-activity associated expnsions, immunity to gut commensal
IgG4-related disease, a case report
Tubule-derived exosomes play a central role in fibroblast activation and kidney
intestinal microbiota control acute kidney injury severity by immune modulation
TAZ/Wnt-β-dacatenin/c-MYC axis regulates cystogenesis in polycystic kidney
Long-Term High-Fat Diet Decreases Renal Insulin-Degrading Enzyme Expression and
Concurrent IgA Nephropathy and Membranous Nephropathy
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Rec
Fusobacterium nucleatum--rheumatoid arthritis
ANXA1通过促进DN炎症消退减轻肾损伤(Kidney International)
NCAM1 is novel autoantigen in MLN
IgAN IgAV- Kdigo Guideline
Rituximab in IMN
Protocadherin 7-Associated Membranous Nephropathy
MN kdigo guideline
urinary exosomal hsa-circ-0001250
Altered glycosylation of IgG4 promotes lectin complement pathway activation MN
Gut microbiota and CKD
immunosuppression for progressive Membranous nephropathy
沙库巴曲缬沙坦降低射血分数保留型心衰患者收缩压
PLA2R autoantibodies and clinical outcome in patients with PMN
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
IgG4糖基化可以通过凝集素补体途径加重MN
Rituximab for Severe Membranous Nephropathy
F . nucleatum targets lncRNA ENO1- IT1 to promote glycolysis and oncogenesis in
Canagliflozin reduces inflammation and fibrosis biomarkers